Patent · US Active

Products and methods for treatment of familial amyotrophic lateral sclerosis

US10793861B2 · kind B2 · utility

8Cited by
7References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 20, 2018
Grant dateOct 6, 2020
Priority date
Expiry dateOct 10, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to RNA-based methods for inhibiting the expression of the superoxide dismutase 1 (SOD-1) gene. Recombinant adeno-associated viruses of the invention deliver DNAs encoding RNAs that knock down the expression of SOD-1. The methods have application in the treatment of amyotrophic lateral sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.